Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials

Obesity Reviews

Volumn 19, Issue 2, 2018, Pages 219-232

  Borgeraas, H ^a   Johnson, L K ^a   Skattebu, J ^a   Hertel, J K ^a   Hjelmesaeth J ^a,b  

^a VESTFOLD HOSPITAL TRUST   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Meta analysis; obesity; probiotics; systematic review

Indexed keywords

ANTIOBESITY AGENT; GLUCOSE; PROBIOTIC AGENT; YOGHURT;

ABDOMINAL FAT; ANTHROPOMETRIC PARAMETERS; BODY MASS; BODY WEIGHT; CHEESE; COLONY FORMING UNIT; DIET RESTRICTION; DIETARY SUPPLEMENT; DRUG CAPSULE; DRUG EFFECT; EFFECT SIZE; FAT MASS; FAT PERCENTAGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; META ANALYSIS; MILK; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOYBEAN MILK; SYSTEMATIC REVIEW; WEIGHT REDUCTION; BODY WEIGHT LOSS; DIET THERAPY; FACTUAL DATABASE; PHYSIOLOGY;

BODY MASS INDEX; BODY WEIGHT; DATABASES, FACTUAL; HUMANS; OBESITY; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WEIGHT LOSS;

EID: 85031509088     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12626     Document Type: Review

References (50)

1. Ng M, Fleming T, Robinson M et al. Global, regional and national prevalence of overweight and obesity in children and adults 1980–2013: a systematic analysis. Lancet (London, England) 2014; 384(9945): 766–781.
2. Collaboration NCDRF. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 2016; 387(10026): 1377–1396.
3. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005; 102(31): 11070–11075.
4. Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012; 489(7415): 242–249.
5. Nieuwdorp M, Gilijamse PW, Pai N, Kaplan LM. Role of the microbiome in energy regulation and metabolism. Gastroenterology 2014; 146(6): 1525–1533.
6. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307(5717): 1915–1920.
7. Cani PD, Lecourt E, Dewulf EM et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 2009; 90(5): 1236–1243.
8. Sayin SI, Wahlstrom A, Felin J et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013; 17(2): 225–235.
9. Watanabe M, Morimoto K, Houten SM et al. Bile acid binding resin improves metabolic control through the induction of energy expenditure. PLoS One 2012; 7(8): e38286.
10. Alcock J, Maley CC, Aktipis CA. Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. Bioessays 2014; 36(10): 940–949.
11. Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G. Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500.
12. Cotillard A, Kennedy SP, Kong LC et al. Dietary intervention impact on gut microbial gene richness. Nature 2013; 500(7464): 585–588.
13. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444(7122): 1027–1031.
14. Sanders ME. Probiotics and microbiota composition. BMC Med 2016; 14(1): 82.
15. Eloe-Fadrosh EA, Brady A, Crabtree J et al. Functional dynamics of the gut microbiome in elderly people during probiotic consumption. MBio 2015; 6(2):1–12.
16. McNulty NP, Yatsunenko T, Hsiao A et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med 2011; 3(106): 106ra.
17. Kristensen NB, Bryrup T, Allin KH, Nielsen T, Hansen TH, Pedersen O. Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med 2016; 8(1): 52.
18. Drissi F, Raoult D, Merhej V. Metabolic role of lactobacilli in weight modification in humans and animals. Microb Pathog 2016; 106: 182–194.
19. Zhang Q, Wu Y, Fei X. Effect of probiotics on body weight and body-mass index: a systematic review and meta-analysis of randomized, controlled trials. Int J Food Sci Nutr 2015; 67(5): 571–580.
20. Higgins JPT, Altman DG, Gøtzsche PC et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343.
21. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration: London, UK, 2011 Available from: www.cochrane-handbook.org.
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327(7414): 557–560.
23. Asemi Z, Zare Z, Shakeri H, Sabihi SS, Esmaillzadeh A. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab 2013; 63(1–2): 1–9.
24. Bernini LJ, Simao AN, Alfieri DF et al. Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: A randomized trial. Effects of probiotics on metabolic syndrome. Nutrition 2016; 32(6): 716–719.
25. Leber B, Tripolt NJ, Blattl D et al. The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study. Eur J Clin Nutr 2012; 66(10): 1110–1115.
26. Tripolt NJ, Leber B, Blattl D et al. Short communication: Effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, beta-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome – a pilot study. J Dairy Sci 2013; 96(1): 89–95.
27. Savard P, Lamarche B, Paradis ME, Thiboutot H, Laurin E, Roy D. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults. Int J Food Microbiol 2011; 149(1): 50–57.
28. Sanchez M, Darimont C, Drapeau V et al. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br J Nutr 2014; 111(8): 1507–1519.
29. Wong VW, Won GL, Chim AM et al. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann Hepatol 2013; 12(2): 256–262.
30. Shavakhi A, Minakari M, Firouzian H, Assali R, Hekmatdoost A, Ferns G. Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: a Double Blind Randomized Clinical Trial. Int J Prev Med 2013; 4(5): 531–537.
31. Fathi Y, Faghih S, Zibaeenezhad MJ, Tabatabaei SH. Kefir drink leads to a similar weight loss, compared with milk, in a dairy-rich non-energy-restricted diet in overweight or obese premenopausal women: a randomized controlled trial. Eur J Nutr 2016; 55(1): 295–304.
32. Woodard GA, Encarnacion B, Downey JR et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg 2009; 13(7): 1198–1204.
33. Nakamura F, Ishida Y, Aihara K et al. Effect of fragmented Lactobacillus amylovorus CP1563 on lipid metabolism in overweight and mildly obese individuals: a randomized controlled trial. Microb Ecol Health Dis 2016; 27: 30312.
34. Agerholm-Larsen L, Raben A, Haulrik N et al. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 2000; 54(4): 288–297.
35. Chung HJ, Yu JG, Lee IA et al. Intestinal removal of free fatty acids from hosts by Lactobacilli for the treatment of obesity. FEBS Open Bio 2016; 6(1): 64–76.
36. Hariri M, Salehi R, Feizi A, Mirlohi M, Kamali S, Ghiasvand R. The effect of probiotic soy milk and soy milk on anthropometric measures and blood pressure in patients with type II diabetes mellitus: a randomized double-blind clinical trial. ARYA Atheroscler 2015; 11(Suppl 1): 74–80.
37. Higashikawa F, Noda M, Awaya T et al. Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial. Eur J Clin Nutr 2016; 70(5): 582–587.
38. Jones ML, Martoni CJ, Tamber S, Parent M, Prakash S. Evaluation of safety and tolerance of microencapsulated Lactobacillus reuteri NCIMB 30242 in a yogurt formulation: a randomized, placebo-controlled, double-blind study. Food Chem Toxicol 2012; 50(6): 2216–2223.
39. Kadooka Y, Sato M, Imaizumi K, Ogawa A, Ikuyama K, Akai Y. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 2010; 64: 636–643.
40. Kadooka Y, Sato M, Ogawa A et al. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. Br J Nutr 2013; 110(9): 1696–1703.
41. Nabavi S, Rafraf M, Somi MH, Homayouni-Rad A, Asghari-Jafarabadi M. Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. J Dairy Sci 2014; 97(12): 7386–7393.
42. Lee SJ, Bose S, Seo JG, Chung WS, Lim CY, Kim H. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial. Clin Nutr 2014; 33(6): 973–981.
43. Madjd A, Taylor MA, Mousavi N et al. Comparison of the effect of daily consumption of probiotic compared with low-fat conventional yogurt on weight loss in healthy obese women following an energy-restricted diet: a randomized controlled trial. Am J Clin Nutr 2016; 103(2): 323–329.
44. Minami J, Kondo S, Yanagisawa N et al. Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial. J Nutr Sci 2015; 4: e17.
45. Sharafedtinov KK, Plotnikova OA, Alexeeva RI et al. Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients – a randomized double-blind placebo-controlled pilot study. Nutr J 2013; 12: 138.
46. Simon MC, Strassburger K, Nowotny B et al. Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept. Diabetes Care 2015; 38(10): 1827–1834.
47. Zarrati M, Salehi E, Nourijelyani K et al. Effects of probiotic yogurt on fat distribution and gene expression of proinflammatory factors in peripheral blood mononuclear cells in overweight and obese people with or without weight-loss diet. J Am Coll Nutr 2014; 33(6): 417–425.
48. Jung SP, Lee KM, Kang JH et al. Effect of Lactobacillus gasseri BNR17 on Overweight and Obese Adults: a Randomized, Double-Blind Clinical Trial. Korean J Fam Med 2013; 34(2): 80–89.
49. Moher D, Hopewell S, Schulz KF et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c869.
50. Dror T, Dickstein Y, Dubourg G, Paul M. Microbiota manipulation for weight change. Microb Pathog 2017; 106: 146–161.